Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats

Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats

<i>Background</i>: The higher consumption of fat and sugar are associated with obesity development and its related diseases such as non-alcoholic fatty liver disease (NAFLD). Lycopene is an antioxidant whose protective potential on fatty liver degeneration has been investigated. The aim...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Mariane Róvero Costa, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Fabiane Valentini Francisqueti-Ferron, Fabiana Kurokawa Hasimoto, Cristina Schmitt Gregolin, Dijon Henrique Salomé de Campos, Cleverton Roberto de Andrade, Ana Lúcia dos Anjos Ferreira, Camila Renata Corrêa, Fernando Moreto
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2019-08-01
Sarja:Antioxidants
Aiheet:
metabolic syndrome
NAFLD
hypercaloric diet
obesity
Linkit:https://www.mdpi.com/2076-3921/8/8/276

Internet

https://www.mdpi.com/2076-3921/8/8/276

Samankaltaisia teoksia